NASDAQ: SION · Biotechnology
Over the past week, Sionna Therapeutics (SION) logged 1 mention across Reddit, X and news, and the read is an Adanos Hold. That is too little tracked discussion to read a direction from, so the signal stays neutral. Wall Street is more cautious, with 1 of 11 analysts rating SION a buy.
Tracked discussion on SION is too thin this week to read a direction from, which is why it reads as a Hold.
Wall Street’s 9% buy share sits next to a crowd that ranges from X at 0% to News at 100%. No other tracker puts the two side by side.
11 analysts have weighed in: a Hold consensus: 1 buy call against 0 sell, with an average 12-month price target of $21.00.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week SION carries too few tracked mentions to weigh any of them, so the read is Hold rather than a clear buy or sell.
The crowd runs 24 points hotter than the 9% analyst buy share, retail is ahead of the Street here. The split is inside the crowd: News reads 100% bullish while X sits at 0%, a 100-point spread that single-source trackers miss.
Over the 30-day window, Sionna Therapeutics (SION) buzz held subdued around 18.5 while the price drifted down 10.9% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 1.5M shares. Updated Sep 26, 2026. Over the last 7 trading days, SION lost 27.2%. Buzz activity in the recent week averaged 19.3 and was relatively stable, swinging between 18.5 and 20.0. Recent volume is running above the 30-day average, suggesting heightened trading interest. Daily crowd sentiment leaned bearish on 3 of the 6 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for SION and 2110+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live SION sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Sep 26, 2026.
| Adanos signal | Hold |
|---|---|
| Analyst consensus | Hold (1 / 10 / 0) |
| Crowd bullish (7d) | 33% |
| Avg price target | $21.00 |
| Most bullish source | News, 100% |
| Most bearish source | X, 0% |
| Sentiment spread | 100 pts |
| Mentions (7d) | 1 |
| Market cap | $236.1M |
| EPS · Beta | -$2.04 · n/a |
| Industry | Biotechnology |
Adanos will not call Sionna Therapeutics (SION) either way right now. The last 7 days carry 1 tracked mention across 3 sources, under the 10-mention floor, so the signal sits at a neutral hold with 40/100 conviction. This is a sentiment-based reading, not financial advice.
Reddit discussion around Sionna Therapeutics (SION) is fairly quiet with 0 mentions over the last 7 days; the 30-day context spans 1 tracked subreddits. The 7-day tone is 0% bullish; 3-day activity momentum is stable, suggesting steady attention.
There is not enough tracked discussion on Sionna Therapeutics (SION) to call it either way. The last 7 days carry 1 tracked mention across 3 sources, under the 10-mention floor Adanos needs before it reads a direction. On the professional side, 1 of 11 analysts rate SION a buy.
Of the 11 analysts covering Sionna Therapeutics (SION), 1 rate it a buy, 10 a hold and 0 a sell, for a hold consensus. The average price target is $21.00. The crowd is the more bullish of the two, averaging 33%.
Sionna Therapeutics (SION) does not carry enough tracked discussion this week to have a readable sentiment. 1 mention across 3 sources is under the 10-mention floor, so the signal stays neutral at 40/100 conviction.
Not for a reason found in the sentiment itself. Sionna Therapeutics (SION) drew 1 tracked mention in the last 7 days, too small a sample to read a direction from, so Adanos holds the signal neutral instead of calling a buy or sell off it.
News is the dominant discussion channel with 1 mention (100% of total volume). There is too little of it to read a sentiment direction from.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. SION's hold signal at 40/100 conviction reflects a sample too thin to read a direction from. It is a research shortcut, not financial advice.
The SION sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Hold signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key